Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crispr Therapeutics AG (CRSP) vs Unilever plc (UL) Price & Performance

Crispr Therapeutics AGTrade
Unilever plcTrade

Price performance (Past 24H)

Key statistics

Crispr Therapeutics AG vs Unilever plc — how do they compare? Crispr Therapeutics AG trades at $53.9 (market cap $5.23B), while Unilever plc trades at $61.89 (market cap $134.06B). The key difference: Unilever plc is far larger — about 25.6× Crispr Therapeutics AG's market cap, and Unilever plc pays a 3.65% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.

CRSPUL
Market Cap
$5.23B$134.06B
Sector
HealthConsumer Staples
52-Week High
$76.78$74.59
52-Week Low
$44.34$55.05
Enterprise Value
$3.65B$159.86B
Dividend Yield
3.65%

Returns comparison

Trailing returns across standard periods

About Crispr Therapeutics AG

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.

Read more on CRSP

About Unilever plc

Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years

Read more on UL